GDP growth may propel to 7.3 per cent in FY20 GDP growth may propel to 7.3 per cent in FY20 Aakash Makhija / Thursday, January 24, 2019 / Article rating: 5.0 GDP growth is expected to accelerate to 7.2 per cent in 2018-19 and further to 7.3 per cent in 2019-20, according to top rating agency Crisil. The report predicts retail inflation to rise substantially to 4.5 per cent in 2019-20.
Results to watch out on Friday, January 25 Results to watch out on Friday, January 25 Shohini Nath / Thursday, January 24, 2019 / Article rating: 3.3 The following stocks would be in focus during Friday’s trading session in light of their results announcement on January 25 : DHFL, GRUH Finance, L&T, Maruti Suzuki and Mahindra & Mahindra Finance.
Ravneet Gill to lead Yes Bank; Net NPA at 1.18 per cent Ravneet Gill to lead Yes Bank; Net NPA at 1.18 per cent Pratik Shastri / Thursday, January 24, 2019 / Article rating: 4.7 Yes Bank announced fairly stable results for Q3FY19 during market hours on Thursday. Bank named Ravneet Gill as the new MD and CEO with effect from March 1.
EFS reports 4 per cent drop in PAT EFS reports 4 per cent drop in PAT Dnyanada Kulkarni / Thursday, January 24, 2019 / Article rating: 5.0 Edelweiss Financial Services (EFS) reported a rise of 25 per cent YoY in the total income of Rs. 2,791 crore in Q3FY19 as against Rs. 2,224 core in Q3FY18. However, PAT dropped to Rs. 226 crore in Q3FY19 from Rs. 235 crore in Q3FY18, thereby sinking 4 per cent YoY.
Q3 Result Analysis: Indigo registers a PAT turnaround Q3 Result Analysis: Indigo registers a PAT turnaround Aakash Makhija / Thursday, January 24, 2019 / Article rating: 5.0 The company's net profit fell 75 per cent on year-on-year basis, as it had reported a net profit of Rs. 762 crore in the same period last year. The drop in the profit was due to 31 per cent increase in fuel cost and depreciation of the Indian rupee during this quarter when compared to the same period last year.
Dr. Reddys launches propofol emulsion in US market Dr. Reddys launches propofol emulsion in US market Gayathri Udyawar / Thursday, January 24, 2019 / Article rating: 5.0 Leading pharma company Dr. Reddy's Laboratories launches propofol injectable emulsion, USP in the US market. The drug is a therapeutic equivalent and a generic version of anaesthesia drug Diprivan injectable emulsion approved by the US drug regulator.
Ten stocks close to their 52-week low Ten stocks close to their 52-week low Shital Jibhe / Thursday, January 24, 2019 / Article rating: 5.0 Following stocks are close to their 52-week low as at 12.45 p.m. on January 24, 2019.
Ten stocks close to their 52-week high Ten stocks close to their 52-week high Shital Jibhe / Thursday, January 24, 2019 / Article rating: 5.0 The markets on January 24, 2019 opened gap down. BSE Sensex is trading at 36,097.45, down by 11.02 points and the Nifty is trading at 10,820.75, down by 10.75 points.
Is it worth investing in large & mid-cap mutual funds? Is it worth investing in large & mid-cap mutual funds? Henil Shah / Thursday, January 24, 2019 / Article rating: 5.0 Reclassifying mutual fund categories, SEBI introduced one new category under the broader category of equity schemes, viz. Large & mid-cap category. Let’s find out whether is it worth investing in this new category or you can just ignore it.
Five stocks with selling interest Five stocks with selling interest Shital Jibhe / Thursday, January 24, 2019 / Article rating: 5.0 Overall volumes in futures & options currently stand at 1.38 crore contracts with a turnover of Rs. 8,22,817.44 crore.